{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:40:04Z","timestamp":1791852004068,"version":"4.3.4"},"reference-count":32,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Clinical Toxicology"],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.1080\/15563650.2025.2608229","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:29:42Z","timestamp":1770042582000},"page":"274-281","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Clinical features and sociodemographic characteristics associated with analytically confirmed exposure to MDMB-4en-PINACA"],"prefix":"10.1080","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2618-1973","authenticated-orcid":false,"given":"Emma Jayne","family":"Moyns","sequence":"first","affiliation":[{"name":"National Poisons Information Service, Birmingham Unit, City Health Campus","place":["Birmingham, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2408-9719","authenticated-orcid":false,"given":"Lauren","family":"Starbrook","sequence":"additional","affiliation":[{"name":"Sandwell and West Birmingham NHS Trust","place":["Birmingham, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0594-6586","authenticated-orcid":false,"given":"Mark","family":"Pucci","sequence":"additional","affiliation":[{"name":"National Poisons Information Service, Birmingham Unit, City Health Campus","place":["Birmingham, UK"]},{"name":"Sandwell and West Birmingham NHS Trust","place":["Birmingham, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"#cr-split#-e_1_3_2_2_1.1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Initial report on the risk assessment of a new psychoactive substance: methyl 3 3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (MDMB-4en-PINACA) in accordance with Article 5c of Regulation (EC) No 1920\/2006 (as amended). Luxembourg"},{"key":"#cr-split#-e_1_3_2_2_1.2","unstructured":"2023 [cited 2025 Oct 21]. Available from: https:\/\/www.emcdda.europa.eu\/publications\/risk-assessments\/mdmb-4en-pinaca_en"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15967"},{"key":"e_1_3_2_4_1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Synthetic cannabinoids in Europe (Perspectives on drugs). Lisbon (Portugal); 2017 [cited 2025 Oct 30]. Available from: https:\/\/www.euda.europa.eu\/publications\/pods\/synthetic-cannabinoids_en"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2025.104972"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2022.2101469"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2019.1661425"},{"issue":"5","key":"e_1_3_2_8_1","first-page":"443","article-title":"Clinical features following analytically confirmed use of 5F-ADB, a synthetic cannabinoid receptor agonist. A report from the UK IONA study","volume":"55","author":"Elamin ME","year":"2017","unstructured":"Elamin ME, Dunn M, Dargan PI, et\u00a0al. Clinical features following analytically confirmed use of 5F-ADB, a synthetic cannabinoid receptor agonist. A report from the UK IONA study. Clin Toxicol. 2017;55(5):443\u2013444.","journal-title":"Clin Toxicol"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2015.1110590"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1313655"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/16066359.2020.1730820"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104219"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAF.0000000000000966"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2025.2489079"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2016.1263663"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1089\/can.2020.0161"},{"key":"e_1_3_2_17_1","unstructured":"Home Office. Review of the Psychoactive Substances Act 2016. London (UK): HM Government; 2018 [cited 2025 Oct 21]. Available from: https:\/\/assets.publishing.service.gov.uk\/media\/5beec777e5274a2b0fd695db\/Review_of_the_Psychoactive_Substances_Act__2016___web_.pdf"},{"key":"#cr-split#-e_1_3_2_18_1.1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Report on the risk assessment of a new psychoactive substance: methyl 3 3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (MDMB-4en-PINACA) in accordance with Article 5c of Regulation (EC) No 1920\/2006 (as amended). Luxembourg"},{"key":"#cr-split#-e_1_3_2_18_1.2","unstructured":"2022 [cited 2025 Dec 16]. Available from: https:\/\/www.euda.europa.eu\/publications\/risk-assessments\/mdmb-4en-pinaca_en"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2024.2309321"},{"issue":"2","key":"e_1_3_2_20_1","first-page":"24","article-title":"Serial quantification of MDMB-4en-PINACA to guide management in a patient with severe synthetic cannabinoid toxicity","volume":"63","author":"Pucci M","year":"2025","unstructured":"Pucci M, Singh Jutley G, Martin H, et\u00a0al. Serial quantification of MDMB-4en-PINACA to guide management in a patient with severe synthetic cannabinoid toxicity. Clin Toxicol. 2025;63(sup2):24\u201325.","journal-title":"Clin Toxicol"},{"key":"e_1_3_2_21_1","unstructured":"Krotulski AW DeBord SE Mohr JS et\u00a0al. NPS Discovery Q3 2025 trend reports. United States; 2025 [cited 2025 Nov 4]. Available from: https:\/\/www.cfsre.org\/images\/trendreports\/2025_Q3_CFSRE_NPS_Discovery_Trend_Reports.pdf"},{"key":"e_1_3_2_22_1","unstructured":"Ministry of Housing CLG. English indices of deprivation 2019. London (UK): Ministry of Housing Communities & Local Government; 2019 [cited 2025 May 10]. Available from: https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2019"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2014.898771"},{"key":"e_1_3_2_24_1","unstructured":"Advisory Council on the Misuse of Drugs. Synthetic Cannabinoic Receptor Agonists (SCRA). London (UK); 2019 [cited 2025 Nov 4]. Available from: https:\/\/assets.publishing.service.gov.uk\/media\/5f983719e90e077afee6bbf8\/FOR_PUBLICATION_-_ACMD_SCRA_report_final.pdf."},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103305"},{"issue":"6","key":"e_1_3_2_26_1","first-page":"537","article-title":"Characteristics and clinical features of patients attending UK emergency departments with analytically-confirmed exposure to the synthetic cannabinoid MDMB-4en PINACA","volume":"59","author":"Thomas SH","year":"2021","unstructured":"Thomas SH, Ketchin A, Issa S, et\u00a0al. Characteristics and clinical features of patients attending UK emergency departments with analytically-confirmed exposure to the synthetic cannabinoid MDMB-4en PINACA. Clin Toxicol. 2021;59(6):537\u2013538.","journal-title":"Clin Toxicol"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/164_2018_135"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.14982"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610300"},{"issue":"6","key":"e_1_3_2_30_1","first-page":"538","article-title":"Changing patterns of synthetic cannabinoid receptor agonists encountered in UK emergency departments","volume":"59","author":"Thomas SH","year":"2021","unstructured":"Thomas SH, Vidler D, Officer J, et\u00a0al. Changing patterns of synthetic cannabinoid receptor agonists encountered in UK emergency departments. Clin Toxicol. 2021;59(6):538\u2013538.","journal-title":"Clin Toxicol"},{"key":"e_1_3_2_31_1","unstructured":"Announcement on Adding 18 Substances Including Synthetic Cannabinoids and 2-(2-Fluorophenyl)-2-(methylamino) cyclohexan-1-one to the supplementary list. 2021 [cited 2025 Nov 15]. Available from: https:\/\/www.mps.gov.cn\/n2255079\/n6865805\/n7355748\/n7913217\/c8129655\/content.html"}],"container-title":["Clinical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15563650.2025.2608229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:17:41Z","timestamp":1775045861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15563650.2025.2608229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,3]]}},"alternative-id":["10.1080\/15563650.2025.2608229"],"URL":"https:\/\/doi.org\/10.1080\/15563650.2025.2608229","relation":{},"ISSN":["1556-3650","1556-9519"],"issn-type":[{"value":"1556-3650","type":"print"},{"value":"1556-9519","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}